Stocks Slip as Pand...
Health Care: Drugs
Synergy Pharmaceuticals Inc. (SGYP: NASDAQ)
$5.11 0.06 | 1.19%
05/23/13 - 04:00 PM ET
Portfolios with SGYP
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- UserGopher Gold
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Userpoore mans portfolio
Latest SGYP Headlines from TheStreet
- Synergy Pharmaceuticals Presents Plecanatide Results From A Large Multicenter Clinical Study At Late-Breaking Abstract Session During Digestive Disease Week 2013 05.21.13 | 10:05 am
- Synergy Pharmaceuticals Added To NASDAQ Biotechnology Index 05.14.13 | 08:05 am
- Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results 05.09.13 | 05:05 pm
- Synergy Pharmaceuticals' Chief Scientific Officer To Give Plenary Lecture On Plecanatide And SP-333 At The 15th Annual TIDES Summit 05.09.13 | 08:05 am
- Synergy Pharmaceuticals Becomes Oversold (SGYP) 04.23.13 | 04:04 pm
- Synergy Pharmaceuticals Announces Closing Of Public Offering Of Shares Of Common Stock 04.16.13 | 11:04 am
- Synergy Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common Stock 04.10.13 | 08:04 pm
- Synergy Pharmaceuticals Inc. Announces Public Offering Of Common Stock 04.09.13 | 04:04 pm
- Synergy Pharmaceuticals Reports 2012 Fourth Quarter And Full-Year Financial Results 03.18.13 | 05:03 pm
- Synergy Pharmaceuticals To Present Study Results From Plecanatide Phase IIb/III Trial In Late-Breaking Clinical Abstract At Digestive Disease Week 2013 03.15.13 | 05:03 am
Press Releases for SGYP
- Synergy Pharmaceuticals To Present Scientific Posters At The Upcoming Gastroenterology Society Meetings In The U.S. And Europe - PR Newswire 07.31.12 | 12:07 pm
- Synergy Pharmaceuticals To Present At 14th Annual BIO CEO & Investor Conference - Business Wire 02.09.12 | 08:02 am
- Synergy Pharmaceuticals Engages The Trout Group For Investor Relations Services - Business Wire 02.08.12 | 08:02 am
- European Patent Office Upholds Synergy Pharmaceuticals’ Grant Of Claims To Plecanatide - Business Wire 01.04.12 | 06:01 am
- Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option By Aegis Capital Corp. - Business Wire 12.13.11 | 04:12 pm
- Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. And Its Chief Scientific Officer And Senior VP Of R&D, Dr. Mark G. Currie - Business Wire 12.13.11 | 03:12 am
- Synergy Pharmaceuticals Inc. Announces Pricing Of Public Offering Of 1,875,000 Units, Listing On NASDAQ And Effectiveness Of Reverse Stock Split - Business Wire 12.01.11 | 08:12 am
- Synergy Pharmaceuticals Raises $5.64 Million In Financing - Business Wire 11.15.11 | 05:11 am
- Synergy Pharmaceuticals And Fox Chase Cancer Center Presentation At 2011 ACG Meeting Highlights Potential Of GC-C Agonists To Delay Progression Of Colitis Into Colon Cancer - Business Wire 10.31.11 | 06:10 am
- Synergy Pharmaceuticals Initiates Dosing Of Patients In Phase II/III Trial Of Plecanatide In Chronic Constipation - Business Wire 10.24.11 | 06:10 am
Partner Headlines for SGYP
- 5 Healthcare Companies With Recent Insider Buying - Seeking Alpha 11.18.12 | 09:11 am
- IND Submission by Synergy Pharma - Analyst Blog - NASDAQ 09.17.12 | 09:09 pm
- Synergy Acquires FV-100 from BMY - Analyst Blog - NASDAQ 08.28.12 | 10:08 pm
- Synergy Acquires FV-100 from BMY - Analyst Blog - Zacks 08.28.12 | 06:08 pm
- Key Appointment Marks Another Win For Synergy Pharmaceuticals - Seeking Alpha 05.03.12 | 09:05 am
